BIO-RAD LABORATORIES-A (BIO) Stock Cash Flow
USA - New York Stock Exchange - NYSE:BIO - US0905722072 - Common Stock
317.69 USD
-2.37 (-0.74%)
317.69 USD
0 (0%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 63.00M | 106.20M | 108.26M | 85.80M | 47.80M | |||
| Interest Paid | -46.00M | -46.50M | -47.49M | -24.40M | -2.30M | |||
| Taxes Paid | -77.30M | -99.00M | -130.00M | -158.30M | -134.70M | |||
| OPERATING CASH FLOW | 491.50M | 455.20M | 374.94M | 194.40M | 669.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -154.80M | -189.00M | -156.68M | -112.80M | -133.70M | |||
| Other Investing Activity | -30.90M | 28.80M | 176.89M | -1.09B | -663.60M | |||
| INVESTING CASH FLOW | -185.70M | -160.20M | 20.21M | -1.21B | -797.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -340.00K | -400.00K | -467.00K | 1.19B | -3.00M | |||
| Stock Issued/Repurchased | -280.00M | -184.40M | -410.24M | -198.10M | -29.40M | |||
| Other Financing Activity | -32.70M | -34.00M | -14.94M | -14.00M | -23.00M | |||
| FINANCING CASH FLOW | -312.30M | -218.80M | -425.65M | 973.60M | -55.40M | |||
| Exchange Rate Effect | -6.68M | 9.20M | 321.00K | 3.00M | -12.60M | |||
| CHANGE IN CASH | -13.18M | 85.40M | -30.18M | -36.60M | -195.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 491.50M | 455.20M | 374.94M | 194.40M | 669.50M | |||
| Capital Expenditure | -154.80M | -189.00M | -156.68M | -112.80M | -133.70M | |||
| FREE CASH FLOW | 336.70M | 266.20M | 218.26M | 81.60M | 535.80M | |||
All data in USD